03: Mythen der Life Sciences und ihre Konsequenzen
-
Hauptschule
Breakout
/
in englischer SpracheGerade in den Life Sciences unterscheidet sich die Wahrnehmung – nicht nur einer wenig technikaffinen Öffentlichkeit, sondern oft auch von Entscheidungsträgern – von den aktuell vorhandenen Möglichkeiten und Gegebenheiten. Der Arbeitskreis soll anhand einiger pointierter Beispiele wesentliche Unterschiede zwischen Fakten und Fiktion herausarbeiten, Mythen entlarven, aber auch in jenen Fällen, wo Klischees zutreffen, diese bestätigen und Perspektiven zur Überwindung der entsprechenden Barrieren erörtern.
| |||||
| |||||
| |||||
| |||||
| |||||
| |||||
| |||||
| |||||
| |||||
|
Ph.D. Dr. rer. nat. habil. Walter H. GÜNZBURG
Professor of Virology and Head, Institute of Virology, University of Veterinary Sciences, Vienna
| Received his Ph.D. in London on the control of eukaryotic gene expression by DNA methylation. After two postdoctoral positions in the U.S.A. and Switzerland, he became a group leader at the National Research Centre for Environment and Health (GSF), in Munich, Germany where he spent 8 years working on retroviral vector mediated gene therapy as well as continuing his basic studies on gene expression control in retroviruses. In 1996, he was appointed full Professor of Virology in Vienna, Austria and since then has headed the Research Institute of Virology and Biomedicine in Vienna. In 2004, he additionally became the head of the newly established Christian Doppler Laboratory for Gene Therapeutic Vector Development, working in close collaboration with Biotech and Pharmaceutical industries to develop new retroviral vectors and cell therapy approaches for the treatment of solid tumours. In 2007 the Christian Doppler Society opened a foreign module focusing on virology and nanotechnology in Singapore under his leadership. Over the last ten years Prof Günzburg has been actively involved in European ethics and regulatory affairs in the fields of both xenotransplantation and gene therapy. |
John HODGSON
Co-Founder and Director, Critical I Limited, Banbury
| Co-founder and Director of Critical I, a business development and business intelligence consultancy, specialising in the life sciences. Critical I supplies data and analysis of the life science sector to government ministries, regional development agencies, and other clients. Critical I also helps deserving early stage European biotechnology companies with business development, marketing, and fund raising. | |
| His assignments in the last two years include providing regulatory advice to an agrochemicals multinational; providing market analysis and positioning advice to a filtration technology company entering the biotechnology market; identifying potential acquisition targets for a leading quoted bioinformatics company; and evaluating potential investments on behalf of a number of the world's largest venture capital funds. John trained as a microbiologist and has followed the biotechnology sector since the early 80s. | |
| Since 1997, he has been a consultant in the field, advising biotech start-ups, venture capital funds, major companies in the pharmaceutical and agrochemical sector, scientific foundations, university tech transfer organisations, and European Commission and UK Government bodies on aspects of biotechnology ranging from business planning, fundraising, risk management and technology trends. | |
| Before 1997, John was a science and business writer as Senior Editor with Nature Biotechnology, the leading journal in the field, and before that Editor of Trends in Biotechnology. He is still Editor at Large of Nature Biotechnology, contributing occasional editorials and sage advice. | |
| In 2002-2003 John was Special Adviser to the UK Parliamentary Trade and Industry Select Committee in its enquiry into the UK biotechnology sector. He is also adviser to BioVision, the World Life Sciences Forum in Lyon, and an organiser of the first Biovision Nobel Days. |
Dipl.-Ing. Dr. techn. Gerfried JUNGMEIER
Deputy Director, LIFE - Centre for Climate, Energy & Society, JOANNEUM RESEARCH Forschungsgesellschaft mbH, Graz
| 1993 | Master degree, Mechanical Engineering, Graz University of Technology |
| since 1993 | Scientist at JOANNEUM RESEARCH |
| 2000 | Ph.D., "Greenhouse Gas Balance of Bioenergy Systems" |
| 2002-2007 | Chair Person, COST Action E31 "Management of Recovered Wood" |
| since 2006 | Lecturer, "Ecological Resource Management", Vienna University of Technology |
| 2007-2015 | National Team Leader, IEA Bioenergy Task 42 "Biorefinery" |
| since 2011 | Operating Agent, IEA HEV Task 30 "Life Cycle Assessment of Electric Vehicles" |
| since 2015 | Operating Agent, IEA HEV Task 33 "Battery Electric Buses" |
| since 2016 | Leader, CCCA Working Group "Consumption based Greenhouse Gas Accounting" |
Dr. Jörg NEERMANN
Partner, LSP - Life Sciences Partners, Munich
| 1987-1993 | Studies in Biotechnology at the Technical University Carolo-Wilhelmina at Brunswick (Germany) and the Massachussetts Institute of Technology (MIT) (USA): Diploma/Masters degree |
| 1993-1996 | Ph.D. thesis (Dr. rer. nat.) at Technical University Carolo-Wilhelmina at Brunswick, German Research Center for Biotechnology (GBF) in parallel studies in economics at Technical University Carolo-Wilhelmina at Brunswick |
| 1996-1998 | Atlas Venture |
| 1998-2006 | DVC Deutsche Venture Capital |
| 2002-2006 | Managing Partner at DVC |
| since 2007 | Partner at LSP Life Science Partners; board member of numerous Life Science Companies |
Dr. Johan VANHEMELRIJCK
Former Secretary General, EuropaBio - European Association for Bioindustries, Brussels
| 1997-1999 | Different European functions, Upjohn company |
| 1989-2002 | Secretary General, European Federation of Animal Health (FEDESA) |
| 2002 | Senior Director Worldwide Industry Affairs for Pharmacia Animal Health |
| since 2003 | CEO of HI&PP Consult |
| 2004-2008 | Secretary General of EuropaBio, the European Association for Bioindustries |
Dr. Erwin F. WAGNER
Vice Director and Programme Director, Cancer Cell Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid
| 1970-1979 | Studies of Biochemistry and Genetics in Graz, Berlin and Innsbruck |
| 1979-1983 | Max-Kade Fellow and Research Associate, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA (U.S.A.) with Dr. B. Mintz |
| 1983-1988 | Group Leader, European Molecular Biology Laboratory, Heidelberg, Germany |
| 1988-1997 | Senior Scientist, Research Institute of Molecular Pathology (IMP), Vienna, Austria |
| 1997-2008 | Deputy Director, IMP, Vienna, Austria |
| since 2008 | Vice Director and Programme Director, Cancer Cell Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain |
lic. oec. HSG Jürg ZÜRCHER
Partner, Industry Leader Biotechnology for Central Europe, Ernst & Young Ltd., Basel
| 1987 | Abschluss des Studiums der Betriebswirtschaftslehre in St. Gallen, Eintritt bei Ernst & Young in Basel |
| 1992 | Diplomierter Wirtschaftsprüfer |
| 1993-1994 | Austauschjahr bei Ernst & Young in den USA |
| 1998 | Ernennung zum Partner bei Ernst & Young Schweiz |
| 2001 | Verantwortlicher für den Biotech-Sektor Schweiz |
| 2005 | Verantwortung für den Biotech-Sektor Zentraleuropa |
| seit 2005 | Mitglied des Global Biotech Advisory Panel von Ernst & Young Global |
Dr. Christiane DRUML
UNESCO Chair, Bioethics, Medical University of Vienna
| Christiane Druml was born in Vienna and studied law at the University of Vienna. She is currently holding the UNESCO Chair on Bioethics at the Medical University of Vienna and also serves as Director of Ethics, Collections and History of Medicine of the Medical University of Vienna. Since 2016 she is Deputy Director & Key Researcher at the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD). 2007 she has been appointed President of the Austrian National Bioethics Commission by the Austrian Federal Chancellor. Furthermore, she is a member of the Medical Council of the Republic of Austria and serves in many international functions. From 2011 to 2015, she was Vice-Rector for Clinical Affairs at the Vienna Medical University. Before that she has been managing director of the Ethics Committee at the Vienna Medical University (1992-2011). Christiane Druml was Member of the International Bioethics Committee IBC of UNESCO from 2008 to 2015 and serves since 2006 as Austrian Member of the General Assembly of the "European and Developing Countries Clinical Trial Partnership- EDCTP". She has been awarded the Austrian Cross of Honour for Science and Arts, and was named Chevalier de la Légion d’Honneur in 2011. |
